Related Experiment Video
Updated: Mar 18, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
Marco Scarpa1, Melania Scarpa2, Ignazio Castagliuolo3
1Esophageal and Digestive Tract Surgery Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy. marcoscarpa73@yahoo.it.
Background:
The lack of positive costimulatory molecules represents one of the mechanisms by which tumor cells evade immune surveillance. Promoter hypermethylation plays a major role in cancer development through transcriptional silencing of critical genes. The aim of this study was to examine the expression of the costimulatory molecule CD80 in relationship with genomic methylation in non-inflammatory colon carcinogenesis.
Methods:
Colonic mucosal samples were collected from healthy subjects (n = 30) and from dysplastic adenoma (n = 14), and colon adenocarcinoma (n = 10). DNA methyltransferases-1, -3a, -3b and CD80 mRNA expression were quantified by real time qRT-PCR. The methylation status of CDH13, APC, MLH1, MGMT1 and RUNX3 gene promoters was assessed by methylation-specific PCR. CD80 expression was assessed in HT29, HCT-15 and LoVo cell lines after treatment with the DNA-methyltransferase inhibitor 5-Aza-2'-deoxycytidine.
Results:
CD80 mRNA levels were significantly lower in the non-inflammatory dysplastic colonic mucosa of patients with one or more methylated genes and inversely correlated with patients' methylation scores (τ = -0.41, p = 0.05 and τ = -0.37, p = 0.05, respectively). Treatment with 5-Aza-2'-deoxycytidine significantly increased CD80 expression both in terms of the level of CD80 mRNA (p = 0.007) and of CD80+ cells (p = 0.003).
Conclusions:
These results indicate that the failure of immune surveillance mechanisms in non-inflammatory colon carcinogenesis may be linked to genomic methylation directly or indirectly affecting CD80 expression.
Insights
Genomic methylation, a key factor in cancer development, silences genes and reduces CD80 expression in colon carcinogenesis. Inhibiting DNA methylation restored CD80 levels, suggesting a link between methylation and immune evasion in colon cancer.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor cells evade immune surveillance partly by lacking positive costimulatory molecules.
- Promoter hypermethylation is a critical mechanism in cancer development, causing transcriptional silencing of genes.
- Non-inflammatory colon carcinogenesis involves complex molecular alterations impacting immune response.
Purpose of the Study:
- To investigate the relationship between CD80 costimulatory molecule expression and genomic methylation in non-inflammatory colon carcinogenesis.
- To determine if altered methylation patterns correlate with reduced CD80 expression in colon tissues.
- To assess the effect of DNA methyltransferase inhibition on CD80 expression in colon cancer cell lines.
Main Methods:
- Quantification of DNA methyltransferases and CD80 mRNA expression using real-time qRT-PCR in colonic mucosal samples from healthy subjects and patients with dysplastic adenoma and colon adenocarcinoma.
- Assessment of methylation status for key genes (CDH13, APC, MLH1, MGMT1, RUNX3) using methylation-specific PCR.
- Evaluation of CD80 expression in colon cancer cell lines (HT29, HCT-15, LoVo) following treatment with the DNA-methyltransferase inhibitor 5-Aza-2'-deoxycytidine.
Main Results:
- CD80 mRNA levels were significantly lower in non-inflammatory dysplastic colonic mucosa, particularly in patients with methylated genes.
- A significant inverse correlation was observed between CD80 mRNA levels and patients' methylation scores.
- Treatment with 5-Aza-2'-deoxycytidine significantly increased both CD80 mRNA levels and the proportion of CD80+ cells in colon cancer cell lines.
Conclusions:
- Genomic methylation plays a role in the reduced expression of the costimulatory molecule CD80 during non-inflammatory colon carcinogenesis.
- The findings suggest that methylation-mediated silencing of CD80 may contribute to the failure of immune surveillance in colon cancer.
- Targeting DNA methylation could potentially restore CD80 expression and enhance anti-tumor immune responses.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

